• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Tema GLP-1, Obesity & Cardiometabolic ETF (NQ: HRTS )

    33.50 UNCHANGED
    Streaming Delayed Price Updated: 4:15 PM EDT, Jul 1, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 33.50
    Bid (Size) 33.22 (2)
    Ask (Size) 45.00 (19)
    Prev. Close 33.50
    Today's Range 33.50 - 33.50
    52wk Range 26.26 - 35.58
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Weight-Loss Drug Forecasts Skyrocket To $150B As Novo Nordisk, Eli Lilly Ramp Up Supply
    The global market for weight-loss drugs is expected to reach a staggering $150 billion by the early 2030s, a significant increase from the previous forecast of $100 billion. This surge is attributed to... 
    Via Benzinga
    Eli Lilly Pops After Weight-Loss Drug Succeeds In Highly Anticipated Sleep Apnea Test
    The results also pressured ResMed, a maker of CPAPs. CPAPs are the common treatment for sleep apnea. 
    Via Investor's Business Daily

    Performance

    YTD
    +9.28%
    +9.28%
    1 Month
    +3.49%
    +3.49%
    3 Month
    -0.95%
    -0.95%
    6 Month
    +9.28%
    +9.28%
    1 Year
    +25.82%
    +25.82%

    More News

    Read More
    Healthcare ETFs For The Weight-Loss Drug Boom And Beyond
    Via Talk Markets
    Topics Artificial Intelligence ETFs
    Exposures Artificial Intelligence
    Weight-Loss Drugs Have One Big Problem. These Drugmakers Are Taking It On.
    Via Investor's Business Daily
    Ozempic, Weygovy – Obesity And Heart Health Constitute A Major Market That Is Only Growing
    Via Benzinga
    Topics ETFs
    Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
    Via Benzinga
    EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads
    Via Benzinga
    Topics ETFs
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.